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Accessible summary
What is known on the subject?
Research findings indicate the percentage of knowledge-related errors in medicines 
management is high, accounting for approximately 75% of all errors, with insuffi-
cient knowledge levels one of the most significant contributors of medication errors. 
Patients should be able to trust nurses to engage therapeutically and actively listen to 
their needs and concerns, responding using skills that are helpful, providing informa-
tion that is clear, accurate, meaningful and free from jargon. However, without knowl-
edge of pharmacology, it is impossible for nurses to be able to provide adequate advice.
What the paper adds to the existing knowledge?
This study has examined an area that had not yet been systematically examined pre-
viously, which draws together previous research findings on mental health nurses' 
knowledge of adverse events, including side effects and medication errors, related to 
antipsychotic medication within NHS inpatient settings.
What are the implications for practice?
A recent study has found that almost three-quarters (73%) of patients taking antip-
sychotic medication reported side effects to some degree. This high number of peo-
ple experiencing antipsychotic medication side effects is likely to compromise care, 
especially in situations where nurses have inadequate knowledge of side effects and 
are unable to provide effective advice to patients.
The findings from this study allow the mental health nursing profession an opportu-
nity to reflect on the best means to increase knowledge and increase patient safety 
awareness and benefits for mental health service users.
Abstract
Introduction: Antipsychotic medications play a significant role in the treatment and 
recovery of people with several psychiatric disorders. However, research findings 
indicate mental health nurses are insufficiently knowledgeable about antipsychotic 
medication side effects.
Aim: To assess practising mental health nurses' knowledge of antipsychotic medi-
cation side effects using a Multiple-Choice Questionnaire (MCQ) across National 
Health Service (NHS) Trusts in England.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, 
provided the original work is properly cited. 
© 2020 The Authors. Journal of Psychiatric and Mental Health Nursing published by John Wiley & Sons Ltd
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1  | BACKGROUND
Antipsychotic medications can play a significant role in the treat-
ment and recovery of people with mental health disorders, and 
in many respects, they are considered a first line of treatment 
for people suffering from a psychotic illness (Leucht et al., 2012). 
Patients and their carers also place a high importance on the use 
of antipsychotics (Gray, Rofail, Allen, & Newey, 2005; Mancini, 
Hardiman, & Lawson, 2005; Piat, Sabetti, & Bloom, 2009) but 
questions remain about their safety and tolerability when used 
long term. An enduring and troubling feature of these medicines 
is their potential for causing serious adverse effects of a degree 
that can obscure the very reason for their prescription in the first 
place. For example, evidence suggests that patients taking anti-
psychotics are three times more likely to die suddenly from cardiac 
arrest or stroke than the general population (Salvo et al., 2016). 
Other potentially fatal side effects include cardiac arrhythmias, 
weight gain, neuroleptic malignancy and the serotonin syndrome. 
Furthermore, an often-overlooked complication of antipsychotic 
usage is, some of their side effects, like akathisia, often mimic un-
derlying mental health symptoms and can be confused with actual 
symptoms of the illness (Mutsatsa et al., 2003). Additionally, there 
is evidence of polypharmacy globally (Barnes & Paton, 2011) and 
an injudicious use of antipsychotics leading to debilitating emo-
tional, cognitive and physical effects on the patient and non-ad-
herence to treatment (Mancini et al., 2005).
Non-adherence to antipsychotics is apparent in a high proportion 
of patients (up to 90%) which can trigger a myriad of problems for 
the patient including illness relapse and re-hospitalization (Higgins, 
2007). In this respect, the use of antipsychotic medicines poses 
important challenges for mental health nurses working in inpatient 
settings. In these settings, nurses are responsible for administering 
each medication dose to the patient, as well as being alert for mon-
itoring potential side effects and their management. Furthermore, 
it is estimated that 40% of a nurse's clinical time is involved with 
medicine-related issues (Armitage & Knapman, 2003) and to com-
pound matters, the repertoire of mental health medicines has ex-
panded over the last six decades and shows no signs of abating, thus 
making the decision-making process more complex (Glick & Rush, 
2016). Consequently, the ability of mental health nurses to manage 
medicines safely and give appropriate advice to patients has been 
called into question (White, 2004).
There is consistent evidence suggesting that nurses in gen-
eral have inadequate working knowledge of pharmacology (Jones, 
Robson, Whitfield, & Gray, 2010; Keijsers et al., 2012; Meechan, 
Mason, & Catling, 2011; Page & McKinney, 2007; Wiernik & Public 
Policy Committee of the American College of Clinical, 2015) and this 
has frequently resulted in suboptimal care to patients. Moreover, 
nurses have reported to be lacking in confidence when discuss-
ing treatment options with patients, carers and medical colleague 
(Bressington, Mui, & Wells, 2013). A lack of knowledge about these 
medicines can lead to errors during the management process as 
demonstrated by a relatively recent study that observed admin-
istration errors accounted for 75% of all medicine-related errors 
(Soerensen, Lisby, Nielsen, Poulsen, & Mainz, 2013) and can result in 
patient harm. For example, anecdotal evidence suggests that nurses 
frequently mistake the side effects of neuroleptic malignant syn-
drome or akathisia with psychotic agitation. This can result in the 
nurse administering when necessary antipsychotic medication (PRN) 
but the solution in this case is to withhold administering antipsychotic 
Hypothesis: Knowledge of antipsychotic medication side effects amongst registered 
mental health nurses is related to their academic qualification, clinical banding and 
length of experience.
Method: A national survey of registered mental health nurses was carried out using 
an online questionnaire which was disseminated by Research and Development 
departments.
Results: A total of 504 questionnaires were returned, 245 of which had full data and 
further analysed. The mean score for the sample was 14.4 and only 21 participants 
attained a mark of >80%.
Implications for Practice: Two out of three of our hypotheses (that length of experi-
ence and clinical banding are directly related to knowledge of antipsychotic medica-
tion side effects) were supported. Our study found many nurses have a suboptimal 
working knowledge of antipsychotic medication side effects which has the potential 
to compromise care. Strategies need to be put in place to enhance pharmacology 
knowledge.
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medication to the patient. In addition to patient harm, medicines er-
rors can cause significant financial burden for healthcare providers 
due to remedial treatment costs and potential litigation expenses 
(Latter, Yerrell, Rycroft-Malone, & Shaw, 2000). Therefore, the eval-
uation of mental health nurses' knowledge of side effects is a valu-
able starting point towards understanding the problem.
Although many studies have examined side effect knowledge 
of mental health nurses, most of these studies used surveys that 
sought student nurses' views (Page & McKinney, 2007) or registered 
nurses and lecturers' views about pharmacology education (Latter 
et al., 2000; Skingsley, Bradley, & Nolan, 2006). A significant draw-
back of self-report approach is nurses often rate their knowledge 
of psychopharmacology as higher than their actual knowledge (Ives, 
Hodge, Bullock, & Marriott, 1996; Meechan et al., 2011). To over-
come this shortcoming, this study used a direct objective question-
naire, exploring registered mental health nurses' knowledge of side 
effects related to antipsychotic medication, within NHS inpatient 
settings. Only one study to our knowledge has systematically and 
directly examined mental health nurse's knowledge of side effects 
(De Hert et al., 2016). However, De Hert et al. only examined the 
side effects of clozapine, with their study based in Belgium.
2  | AIM
The aim of this study was to directly assess practising mental health 
nurses' knowledge of antipsychotic medication side effects using 
a Multiple-Choice Questionnaire (MCQ) across different National 
Health Service (NHS) Trusts in England. Specifically, the study 
sought to test the hypothesis that the knowledge of side effects 
amongst registered mental health nurses is related to their academic 
qualification, clinical banding and length of experience.
3  | METHOD AND DESIGN
This study employed a cross-sectional questionnaire survey to exam-
ine knowledge of antipsychotic medication side effects of registered 
nurses working in inpatient services in the NHS. The questionnaire 
was developed by the authors based on commonly known side ef-
fects as stated in the British National Formulary (BNF, 2017) and com-
mon antipsychotics side effects reported to the National Reporting 
and Learning system (NRLS) from 2005 to 2016. The authors filtered 
the data from the NRLS using the following categories: Mental Health 
Unit/Facility; Inpatient areas; Medication; Patient age range (all avail-
able selected); Patient age at time of event (all ages selected); Speciality 
(Adult mental health, child and adolescent mental health, forensic mental 
health, inpatient assessment and treatment, mental health rehabilitation 
and older adult mental health); Medication Process (all available selected); 
Medication error (all available selected); Degree of harm (all available se-
lected); Antipsychotic medications (other psychotropic medications ex-
cluded); Route (Oral, Intramuscular & ‘blanks’); Year (2005–2016).
Analysis of the NRLS data using the (above) filters, indicated er-
rors related to clozapine, olanzapine, quetiapine, haloperidol, chlor-
promazine and risperidone accounted for approximately 60% of all 
reported incidences. Thus, the survey included MCQs specifically 
related to these antipsychotics.
It was initially piloted on 10 individuals from the first authors NHS 
hospital trust and the feedback received from participants and inter-
pretation of responses led to a reduction in the number of questions 
asked. The final version had 6 items related to demographic data and 
a further 24 questions in the main body. There were 4 answer options, 
with one correct answer only. Each correct answer awarded a mark of 
one, with a possible total score of 24 (100%). A score of 19 (80%) or 
more gave participants a pass mark. This threshold of 80% is generally 
accepted as the standard pass mark for pharmacology and has been 
used in previous studies (Ndosi & Newell, 2009). The questionnaire 
was conducted online and the weblink was disseminated by Research 
and Development departments. All 57 mental health trusts in England 
were invited to participate in the study. The design was deemed ap-
propriate for this study as MCQs can test more than one isolated fact 
recall (McCoubrie & McKnight, 2008). They are appropriate for mea-
suring knowledge and comprehension and can be designed to measure 
application and analysis (Kaur, Singla, & Mahajan, 2016).
Only registered mental health nurses, with a clinical banding of 5 
and above, working in inpatient settings were eligible for the study. 
Clinical banding refers to the pay scale used in the UK's NHS to pay 
employees appropriately, according to their abilities and responsibil-
ities, under the Agenda for Change (AfC) Scheme, 2019. There are 9 
bands (1–9) but this study only included nurses who were a band 5 or 
above as this is the starting clinical band for qualified nurses.
We defined inpatients as any hospital settings where nursing 
staff have responsibility for patient medications and these settings 
include acute admission wards, psychiatric intensive care units and 
recovery settings. To estimate an a priori sample size need for the 
study, a method of power estimation where the population under 
study is known was used (Denscombe, 2014). The Department of 
Health (DH) indicate that there were approximately 19,000 RMNs 
working in NHS inpatient mental health wards at the time of the 
study (Rahman, 2018). Using this figure and a confidence level of 
95%, a sample size of 378 was extrapolated from a chart (Denscombe, 
2014; Krejcie & Morgan, 1970).
4  | PROCEDURE
Ethical approval was obtained from the Health Research Authority 
(HRA) and the Research Ethics Committee based at the academic 
institution the research was completed in, after which recruitment 
of participants in NHS mental health trusts across England was ini-
tiated from September 2017 and ended in mid-February 2018. To 
help with the efficient distribution of the questionnaire nationwide, 
Research and Development (R&D) teams of various NHS trusts were 
enlisted to disseminate the survey. In addition, social media sites 
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(specifically Twitter and Facebook) were used to promote and maxi-
mize exposure of the study.
The data were analysed using SPSS version 24 (IBM, 2018). 
Initially, descriptive statistics were used to explore the demographic 
characteristics of the sample. Further, multiple regression tech-
niques were used to establish relationships between variables and a 
One-Way Analysis of Variance (ANOVA) was used to estimate group 
differences and subsequent post hoc tests.
5  | RESULTS
In total, 504 questionnaires were returned. Of these, 245 (48.6%) 
questionnaires were returned with full data, 165 (32.7%) respond-
ents only entered demographic data and a further 94 (18.7%) clicked 
the link but did not complete any aspect of the survey. The mean 
score for the sample was 14.4 (60%) with a standard deviation of 3.4. 
The scores ranged from 2 (8.3%) to 22 (91.7%) and only 21 (8.6%) out 
of 245 participants attained a mark of 80% or above.
5.1 | Respondents' characteristics
As shown in Table 1, most of the respondents were White British 
and females and this is in accord with previous research that has ex-
amined ethnicity and gender on inpatient psychiatric wards (Bowers, 
Jones, & Simpson, 2009). The sample age ranged from 21 years to 
61 years or over, with most nurses being in the 41–50 years age cat-
egory, accounting for 28.6% of the total sample. Just less than half 
of the respondents, 121 (49.4%), had completed a Bachelor's degree 
with the second largest group (79) having an associate degree/di-
ploma (32.2%). There were only 37 (15.1%) of respondents who had 
completed a master's degree and none who had completed a PhD. 
With regard to clinical banding, most of the respondents worked as 
band 5 (40.0%), band 6 (32.2%), band 7 (20.8%), band 8 or above 
(5.7%). Band 6 nurses recorded the lowest pass rate with only 2.5% 
of participants passing. The group that registered the highest rate 
of passes was the band 8 or above group with 28.6% of participants 
passing. When the percentage of those who passed was analysed 
by level of education further, the data revealed that level of educa-
tional attainment was not associated with pass rates in the survey. 
See Table 2 below for further details.
5.2 | Statistical analysis
The outcome variable of interest (total knowledge scores on the 
MCQ) was tested for normal distribution to justify the use of using 
statistical tests. The data were explored for skewness and kurtosis 
was tested which was 1.3 and −0.8, respectively, suggesting normal 
distribution (Peat & Barton, 2008). For total knowledge scores, the 
mean scores between the groups (clinical banding and educational 
level) were compared using a one-way ANOVA. For clinical banding, 
the results showed there was an in-group difference which was 
statistically significant (F = 4.3, df = 3, p = .01). To determine which 
groups differed, a post hoc Bonferroni test was conducted and re-
vealed that band 8 nurses scored significantly better than band 5 
nurses. However, this was only at trend level (p = .08). For level of 
education, the difference in scores was not statistically significant 
(F = 0.094, df = 2, p = .91). See Table 3 below for further details.
A stepwise linear regression was carried out to determine 
whether nurses' knowledge of antipsychotic medication side effects 
was influenced by age or length of service. Only length of service 
appeared to significantly influence knowledge of antipsychotic med-
ication side effects but accounting for only 4% of the variance (ad-
justed R2 = .04, df = 1, p = .001). This indicates that nurses who have 
been working for a relatively longer period are more likely to have 
a better knowledge of side effects. To determine if the regression 
analysis was sufficiently powered to minimize the potential of a type 
2 error, a confirmatory post hoc power analysis as recommended by 
Soper (2018) was carried out. Using results from the regression anal-
ysis of an effect size of 0.04, a probability level of 0.05 and a sample 
size of 245 revealed that the study is powered at 82%. A sample size 
powered at 80% or above is normally considered to be adequate to 
avoid a type 2 error (Magnusson, 2018). Hence, our a priori sample 
estimate of a minimum of 378 was in fact an overestimate of the true 
sample size required.
6  | DISCUSSION
This study sought to examine the hypothesis that knowledge of side 
effects amongst registered mental health nurses is related to their 
academic qualification, clinical banding, and length of experience. 
The study found that only length of experience and clinical banding 
was related to the level of side effects knowledge. In other words, 
those who have been working as mental health nurses for a longer 
period were more likely to have a better knowledge of antipsychotic 
medication side effects. Equally, those who were of a higher clinical 
banding were more likely to have a better knowledge of side effects 
than those of lower banding. However, higher clinical banding could 
simply reflect length of service.
A key finding from this study is that only 21 (9%) of the nurses 
who took part passed at the 80% threshold. This finding supports 
the view that mental health nurses have a relatively poor knowledge 
of antipsychotic medication side effects and this is in line with pre-
vious findings by De Hert et al. (2016) who assessed side effects 
knowledge of clozapine of 85 mental health nurses in Belgium. They 
found that only 25% of participants passed the test. The difference 
in pass rate between De Hert and colleagues and our study could be 
explained by the pass threshold used. Whilst our study used an 80% 
pass threshold, De Hert and colleagues used a 50% pass threshold 
and focused on clozapine side effects. Furthermore, demographic 
and cultural differences could have accounted for the differences.
From a service user perspective, limited knowledge of side effects 
has led to treatment dissatisfaction according to some investigators. 
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Concerns about nurses' purported lack of recognition and attention 
to adverse medication effects are prominent topics of discussion for 
patient self-support groups (Gray et al., 2005). Considering that a re-
cent study found that nearly three-quarters (73%) of patients taking 
antipsychotics reported side effects to some degree (Iversen et al., 
2018), the findings from this study assume an even greater clinical 
significance.
This relatively high number of people experiencing antipsychotic 
medication side effects is likely to compromise care, especially in 
situations where nurses have inadequate knowledge of side effects 
and are unable to provide effective advice to patients. Patients 
should be able to trust nurses to engage therapeutically and actively 
listen to their needs and concerns, responding using skills that are 
helpful, providing information that is clear, accurate, meaningful and 
free from jargon (Walker, 2014). However, without knowledge of 
pharmacology, it is impossible for nurses to be able to provide ade-
quate advice. This means that patients may continue to have knowl-
edge deficits regarding the effects of medicines and side effects 
of the medications they are taking (Pearson, Carter, McCormick, & 
Wright, 2018). As a result, this is likely to result in treatment dissat-
isfaction which in turn, may lead to treatment non-adherence on the 
part of the patient. Non-adherence to treatment due to unpleas-
ant side effects is relatively common (Velligan, Sajatovic, Hatch, 
Kramata, & Docherty, 2017) and almost always leads to patient re-
lapse (Dibonaventura, Gabriel, Dupclay, Gupta, & Kim, 2012).
The suboptimal knowledge of antipsychotic medication side 
effects is not unique to mental health nurses as previous studies 
have indicated. A study that assessed the confidence of 241 gen-
eral practitioners to prescribe for mental health conditions found 
that 71.5% of the general practitioners reported that they prescribe 
psychotropic medication to their patients despite often assessing 
their own knowledge of these drugs, including side effect knowl-
edge as absent or marginal (Fraser & Oyama, 2013). This finding is 
echoed in an earlier view expressed by eminent psychiatrists in the 
UK who expressed doubts about the adequacy of current clinical 
psychopharmacological training and competence of newly qualified 
psychiatrists. They called for the postgraduate education in psycho-
pharmacology for doctors to be substantial and rigorous (Harrison 
et al., 2011). Overall, findings from our study are consistent with 
previous studies that examined and concluded that antipsychotic 
medication side effects knowledge is inadequate in mental health 
professionals as whole.
TA B L E  1   Demographic data for participants who completed 
survey (n = 245)
Gender  
Male 81 (33.1%)
Female 163 (66.5%)
Total 244 (9.6%)
Missing data 1 (0.4%)
Age (years)  
21—30 61 (24.9%)
31—40 66 (26.9%)
41—50 70 (28.6%)
51—60 39 (15.9%)
61 years and above 8 (3.3%)
Total 244 (9.6%)
Missing data 1 (0.4%)
Ethnicity  
White—British 174 (1.0%)
White—Irish 6 (2.4%)
Any other White background 10 (4.1%)
Mixed—White and Asian 3 (1.2%)
Mixed—White and Black Caribbean 2 (0.8%)
Any other mixed background 1 (0.4%)
Asian or Asian British—Bangladeshi 8 (3.3%)
Asian or Asian British—Indian 6 (2.4%)
Asian or Asian British—Pakistani 2 (0.8%)
Any other Asian background 6 (2.4%)
Black or Black British—African 21 (8.6%)
Black or Black British—Caribbean 2 (0.8%)
Any other ethnic background 3 (1.2%)
Total 144 (99.6%)
Missing data 1 (0.4%)
Highest level of education  
Associates degree/Diploma 79 (32.2%)
Bachelor's degree 121 (49.4%)
Master's degree 37 (15.1%)
PhD 1 (0.4%)
Total 238 (97.1%)
Missing data 7 (2.9%)
Length of practice (years)  
<1 year 19 (7.8%)
1–2 years 28 (11.4%)
3–5 years 38 (15.5%)
6–10 years 51 (20.8%)
11–15 years 27 (11.0%)
15 years and above 78 (31.8%)
Total 241 (8.4%)
Missing data 4 (1.6%)
(Continues)
Current banding  
Band 5 98 (40.0%)
Band 6 79 (32.2%)
Band 7 51 (20.8%)
Band 8 or above 14 (5.7%)
Total 242 (98.8%)
Missing data 3 (1.2%)
Note: Table describing demographic data of questionnaire respondents.
TA B L E  1   (Continued)
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A further, well-recognized clinical significance of the findings is 
that inadequate side effect knowledge can increase the risk for er-
rors (Lu et al., 2013). This view is supported by a systematic review 
by Keers, Williams, Cooke, and Ashcroft (2013), which examined 
54 studies and reported knowledge-based errors to be the most 
commonly reported acts in medicines management within hospital 
settings. Another systematic review of 20 studies found medication 
errors to be as much as 17.5 per 1,000 patient days with adverse 
drug events ranging from 3.3% to 48.0%. Their findings further in-
dicate medication errors and adverse drug events were often asso-
ciated with atypical antipsychotics and associated with patient harm 
(Alshehri, Keers, & Ashcroft, 2017).
The Institute of Medicine (2007) has previously identified 
mental health care as having higher medication errors than any 
other branch of health care with errors potentially leading to pa-
tient harm. This has important health policy implications consid-
ering the Francis Report (Francis, 2013) that emphasized patients 
should be protected from avoidable harm. Patient safety is further 
discussed in the Berwick report (Berwick, 2013) and one of the 
recommended guiding principles for improving patient safety is 
placing the quality and safety of patient care above all other aims 
for the NHS.
In addition to quality and safety, medication errors can have eco-
nomic implications for the healthcare system. In the United Kingdom 
(UK), the Department of Health report states that preventable med-
ication errors cost the NHS by as much as £2.5bn a year (Torjesen, 
2014). This is buttressed by an earlier report from the National 
Patient Safety Agency (NPSA, 2007) that conservatively estimated 
that preventable harm from medicines may cost the NHS in excess of 
£750 million each year in England. It is therefore apparent that med-
ication errors due to inadequate knowledge have important policy 
ramifications at operational and strategic levels.
The inadequate knowledge of side effects has been attributed 
to the way nurses are trained as previous studies have suggested. In 
general, these studies have concluded that nurses are poorly trained 
in pharmacology and have recommended changes in curriculum that 
accommodates more pharmacology in view of the growth of nurse 
prescribing (Morrison et al., 2017; Simonsen, Daehlin, Johansson, 
& Farup, 2014). Other investigators have specifically called for im-
provement in the teaching of psychopharmacology not only for 
nurses, but for doctors and pharmacists as well. This is because cur-
rent teaching in this subject appears insufficient for undergraduate 
doctors, nurses and pharmacists (Gardner, 2014). Moreover, the ex-
plosion in neuro-scientific and psychological understanding of men-
tal disorders have compounded the problem (Glick & Rush, 2016). 
Strategies for teaching psychopharmacology are needed at both pre- 
and post-registration levels to support the development and demon-
stration of minimum competencies for the psychopharmacology for 
TA B L E  2   Breakdown of participants who answered 80% or more of questions correctly
Highest level of education
 Associates degree/Diploma Bachelor's degree Master's degree PhD Total
Pass 9 (11.4%) 9 (7.4%) 2 (5.4%) 0 (0%) 20 (8.4%)
Fail 70 (88.6%) 112 (92.6%) 35 (94.6%) 1 (100%) 218 (91.6%)
Total 79 121 37 1 238
Clinical banding
 Band 5 Band 6 Band 7 Band 8 or above Total
Pass 8 (8.2%) 2 (2.5%) 7 (13.7%) 4 (28.6%) 21 (8.7%)
Fail 90 (91.7%) 77 (97.5%) 44 (86.3%) 10 (71.4%) 221 (91.3%)
Total 98 79 51 14 242
Note: Table describing percentage of scores answered correctly on questionnaire.
TA B L E  3   Means scores for participants
Level of education
 Associate degree/Diploma (n) Bachelor's degree (n) Master's degree (n) PhD (n)
Mean score 14.49 (79) 14.30 (121) 14.27 (37) 16 (1)
Range 4–22 2–21 7–20 16
Clinical banding
 Band 5 (n) Band 6 (n) Band 7 (n) Band 8 or above (n)
Mean score 13.80 (98) 14.30 (79) 15.06 (51) 16.92 (13)
Range 2–22 4–20 4–21 13–20
Note: Mean scores answered correctly on questionnaire based on level of education and clinical banding.
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mental health nurses. This may require continual review and up-
dating to meet the rapidly changing demands of the mental health 
workplace. A greater focus on psychopharmacology at both pre- and 
postgraduate level would benefit patients by improving standards in 
the judicious use of medication.
Despite these well-recognized challenges, it has been argued that 
nurse training has increasingly shifted towards a psychosocial model 
of care in recent years at the expense of biosciences (Skingsley et al., 
2006). The amount of time undergraduates nurses spend on medi-
cine-related aspects of care is disproportionate to the time devoted 
to pharmacology teaching within the clinical area or within academic 
institutions (Morrison-Griffiths, Snowden, & Pirmohamed, 2002).
However, findings from this study also suggest many mental 
health nurses' knowledge of side effects tends to increase with 
experience and this is supported by previous findings (Perehudoff 
et al., 2016) but a cautionary stance is warranted when interpreting 
this finding. No matter how much effort goes into improving expe-
riential learning, it will always be hampered by time constraints and 
competing clinical demands. For example, many mental health ser-
vices have been experiencing problems with recruitment of nurses 
and this has led to an increased use of temporary staff (Addicott, 
Maguire, Honeyman, & Jabbal, 2015). Such an environment is likely 
to compromise experiential learning. In support of this view, the re-
sults from our regression analysis showed that knowledge gained 
through experience accounted for only 4% of the variance, suggest-
ing that 96% of the learning was through other means. Because of 
these limitations, proposals for improving the teaching of psycho-
pharmacology have been discussed (Gardner, 2014; Jones et al., 
2010; Skingsley et al., 2006) but the implementation of these strate-
gies remains a significant challenge.
One such challenge is that, although some universities in the UK 
take a very proactive approach to delivering structured pharmacol-
ogy which includes side effects knowledge (Haw, Stubbs, & Yorston, 
2008), only about 33% of lecturers in UK Universities felt pharma-
cology should be covered in pre-registration curriculum (Bradley, 
Campbell, & Nolan, 2005). From a mental health perspective, this 
raises important questions as 92% of mental health service users in 
the UK are prescribed psychotropic medicines and nurses play a key 
role in the management of these medicines (Healthcare Commission, 
2007). Further, this stance goes against recommendations from the 
Royal College of Psychiatrists and the Royal College of Nursing who 
recommend a greater focus on teaching psychopharmacology and 
physical health to mental health nurses at both pre- and post-regis-
tration level (Gardner, 2014).
7  | STUDY LIMITATIONS
Our study has several limitations which may impact on the gener-
alizability of our findings. First, 259 participants completed demo-
graphic details or returned the questionnaire unanswered and this 
represents missing data and its associated problems. Eight exam-
ples cited in research by Nulty (2008) found most online surveys 
achieved response rates that were much lower than the paper-based 
ones (on average 23% lower).
Face-to-face studies usually have high response rates for partici-
pants. If a participant is willing to show up for a study, it is likely they 
will stay for the entire study, and the researcher will have the ability 
to collect a full set of data (Rice, Winter, Doherty, & Milner, 2017). 
The ability of a researcher to verbally instruct participants and answer 
questions during the research process greatly increases the partici-
pants' understanding of the task they need to complete. However, this 
interaction becomes much more difficult online, where the research-
ers and participants never meet (Crump, McDonnell, & Gureckis, 
2013). Online participants frequently start a study and then abandon 
it after the first few questions. They often review a study to see if it 
is interesting, and then if it does not seem engaging, they will often 
abandon it after the instructions (Buhrmester, Kwang, & Gosling, 
2011). Many researchers have reported that they have trouble getting 
online participants to spend more than 20–30 min on a survey before 
they either quit or start responding randomly. This may explain our 
study finding that 19% clicked the link but did not complete the sur-
vey. As previously observed, this limits a researcher's ability to collect 
accurate data from a time-consuming survey (Crump et al., 2013).
Second, only 25 of the 57 mental health trust research and 
development teams agreed to take part in the study. Many orga-
nizations may have restrictions or are even unwilling to send out 
instruments on behalf of researchers to protect their staff from 
unwanted solicitations. The high proportion of non-participants 
trusts experienced by this study may constitute systematic bias.
Third, questionnaires, specifically MCQs, are deemed to lack va-
lidity with no way of telling how truthful a respondent is being or how 
much thought they have put into their responses (Popper, 2005). It 
will also not be possible to tell if a respondent completes the survey 
themselves or if they receive help (Schmidt, 1997), which will surely 
impact the overall findings. However, the overall low scores and not 
one single respondent answering all questions correctly suggests 
this not to be the case and scores were not simply ‘gamed’ by par-
ticipants wishing to achieve high scores. Rather, it implies individual 
scores are an accurate and real reflection of participants’ knowledge 
levels, and this study obtained an accurate measure of the current 
state of knowledge.
8  | STRENGTHS OF THE STUDY
The statistical power from this study is 0.82 suggesting that the likeli-
hood of avoiding a type 2 error is high. Our use of data from NRLS 
has further increased the construct validity of questions because they 
were informed by real-life incidents. Therefore, the overall question-
naire possesses depth, exploring knowledge levels using meaningful 
questions (Schmidgall, 2017). Another strength of the study is the di-
rect measurement of knowledge using MCQ questionnaire.
There are several advantages of using MCQs as a method of di-
rectly assessing knowledge, one being that they allow the testing of 
a broad range of knowledge in a short space of time and are easy to 
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construct. Despite criticism from some quarters (Brookhart, 2015), 
MCQs are being used more due to higher reliability, validity and 
ease of scoring (Tarrant & Ware, 2012) compared to more traditional 
true/false format MCQs (McCoubrie & McKnight, 2008).
9  | CONCLUSION
The level of pharmacology knowledge demonstrated by men-
tal health nurses remains a contentious issue. This study and 
other previous studies found that many nurses have a subopti-
mal working knowledge of antipsychotic medication side effects. 
Specifically, our study found that the level of knowledge tends 
to improve with length of experience, but the effect size is very 
small. Furthermore, our hypotheses that academic qualification 
(and age) is directly related to knowledge of side effects were 
not supported. Poor knowledge of antipsychotic medication has 
the potential to compromise care mental health nurses provide 
in clinical practice. Strategies need to be put in place to enhance 
pharmacology and specifically side effects knowledge of mental 
health nurses.
10  | RELE VANCE STATEMENT
Drug errors in nursing (including mental health nursing) are common. 
Previous studies suggest many of these errors can be attributed to 
mental health nurses' poor knowledge of psychopharmacology and 
more specifically, side effects. Medicines errors can cause patient 
harm and, in some instances, can be fatal. Despite the importance 
of the subject, to our knowledge, our study is the only one we are 
aware of that has directly assessed mental health nurses' knowledge 
of side effects. Results from our study can potentially influence clin-
ical practice from a therapeutic and safety perspective and shape 
Continuous Professional Development for mental health nurses.
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APPENDIX 1
QUE S TIONNAIRE COMPLE TED BY RE SPONDENTS
Antipsychotic medication side effects knowledge amongst regis-
tered mental health nurses in England: A national survey
D1 What gender are you?
○ Male
○ Female
○ Other
D2 What is your age?
○ 21–30 years
○ 31–40 years
○ 41–50 years
○ 51–60 years
○ 61 years and above
D3 Which of the following best describes your ethnic origin?
○ White - British
○ White - Irish
○ Any other White background
○ Mixed - White and Asian
○ Mixed - White and Black African
○ Mixed - White and Black Caribbean
○ Any other mixed background
○ Chinese
○ Asian or Asian British - Bangladeshi
○ Asian or Asian British - Indian
○ Asian or Asian British - Pakistani
○ Any other Asian background
○ Black or Black British - African
○ Black or Black British - Caribbean
○ Any other Black background
○ Any other ethnic background
D4 What is the highest degree or level of education you have 
completed?
○ Associates degree/Diploma
○ Bachelor's degree
○ Master's degree
○ PhD
D5 How long have you been working as a registered mental health 
nurse?
○ Less than 1 year
○ 1–2 years
○ 3–5 years
○ 6–10 years
○ 11–15 years
○ 15 years and above
D6 What band are you currently working as?
○ Band 5
○ Band 6
○ Band 7
○ Band 8 or above
Q1 A patient suffering from Schizophrenia and treated with first 
generation antipsychotics for 5 years, developed abnormal involun-
tary movement in limbs and face. The patient has:
     |  531BEGUM Et al.
○ Tardive dyskinesia
○ Muscular dystonia
○ Akathisia
○ Neuroleptic malignant syndrome
Q2 A patient on antipsychotic medication has developed an irrita-
ble urge to move limbs and has inner restlessness. This condition is 
called:
○ Akathisia
○ Akinesia
○ Hyperkinesia
○ Dyskinesia
Q3 Akathisia is:
○ A neurotic disease
○ Seen in Schizophrenia
○ A side effect of lithium
○ A side effect of antipsychotic drugs
Q4 Neuroleptic malignant syndrome is characterized by:
○ Bradycardia
○ Labile hypertension
○ Hypotonia
○ Hypothermia
Q5 A side effect of Chlorpromazine, for which anti cholinergic is 
used, is:
○ Blurred vision
○ Oculogyric crisis
○ Hypotension
○ Dry mouth
Q6 Which of the following antipsychotic drugs induces the least ex-
trapyramidal side effects?
○ Haloperidol
○ Thioridazine
○ Clozapine
○ Chlorpromazine
Q7 A 45 year old was brought to casualty with abnormal involuntary 
contraction of the muscles especially of the head and neck. A day 
earlier, she had been prescribed Haloperidol 5 mg three times daily 
by the psychiatrist. Which of the following is the most likely symp-
tom she is suffering from?
○ Acute psychosis
○ Conversion reaction
○ Acute drug dystonia
○ Cerebrovascular accident
Q8 Which of the following statements is incorrect?
○ In psychiatric practice, drug-induced hyperprolactinaemia is most 
likely due to secondary antipsychotic medications effect
○ Although first-generation antipsychotics can cause marked eleva-
tion in prolactin levels, not all secondary-generation antipsychot-
ics have this effect
○ Consideration should be given to other causes of hyperprolacti-
naemia in patients taking antipsychotics if the prolactin levels are 
above the expected range
○ Aripiprazole has only a dopamine antagonist effect.
Q9 Prolactin-sparing antipsychotics tend to show lower frequencies 
of hyperprolactinaemia-associated side effects. Which of the fol-
lowing is not a prolactin-sparing antipsychotic?
○ Clozapine
○ Amisulpride
○ Olanzapine
○ Aripiprazole
Q10 Which of the following is the best answer: Erectile failure in a 
middle-aged man with chronic Schizophrenia and diabetes mellitus, 
undergoing phenothiazine treatment:
○ May improve if the patient is switched to Quetiapine
○ Can be caused by peripheral vascular disease
○ May be due to depression
○ Can respond to sildenafil treatment
Q11 Which of the following is a complication of prescribing high-
dose antipsychotics?
○ Prolonged PR interval
○ Peaked t-wave
○ Prolonged QTc interval
○ Shortened QTc interval
Q12 Neuroleptic malignant syndrome is a potentially fatal side-effect of:
○ Fluphenazine only
○ All antipsychotic drugs
○ Clozapine only
○ Pimozide only
Q13 Choose the best answer: Tardive dyskinesia is an extrapyrami-
dal symptom consisting of which one of the following?
○ Tremor
○ Abnormal face and body movements
○ Restlessness
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○ Rhythmic, involuntary movements of the tongue, face and jaw
Q14 Of the second generation antipsychotic drugs, which of the fol-
lowing has the lowest risk of Diabetes?
○ Amisulpride
○ Risperidone
○ Clozapine
○ Quetiapine
Q15 Choose the best answer: Which of the following statements 
regarding tardive dyskinesia is true?
○ It is the least serious manifestation of extrapyramidal symptoms 
of antipsychotics
○ It may be irreversible on withdrawing therapy and treatment is 
usually ineffective
○ It only develops on long-term therapy
○ It occurs very rarely, especially in the elderly
Q16 Prior to administering any medication, which of the following 
statements is false:
○ You must administer any prescribed medication first and then 
discuss with an authorised prescriber if there are any concerns 
regarding the patient's condition
○ You must have considered the dosage, method of administration, 
route and timing
○ You must contact the prescriber or another authorised prescriber 
without delay where assessment of the patient indicates that the 
medicine is no longer suitable
○ In regards to controlled drugs, the second signatory does not 
need to be another registered professional
Q17 If a patient experiences an adverse reaction, which of the fol-
lowing statements is false?
○ You must take any action to remedy harm caused by the 
reaction
○ You must notify the prescriber
○ It should be recorded in the patient's notes
○ You do not need to notify the Yellow Card Scheme immediately
Q18 Which of the following medication has less sedating and fewer 
anti-muscarinic effects?
○ Promazine
○ Chlorpromazine
○ Haloperidol
○ Levomepromazine
Q19 If a patient has been given the wrong dosage/frequency of 
medication, which of the following do you not need to do?
○ Document your actions
○ Inform your line manager/employer
○ Inform the pharmacist
○ Report to the prescriber as soon as possible
Q20 Weight gain is most commonly associated with which of the 
following antipsychotics?
○ Pimozide
○ Olanzapine
○ Loxapine
○ Perphenazine
Q21 A less common side effect of Quetiapine is?
○ Restless legs syndrome
○ Sexual dysfunction
○ Depression
○ Urinary disorders
Q22 Hyperprolactinaemia is not usually clinically significant with all 
of the following except:
○ Aripiprazole
○ Quetiapine
○ Olanzapine
○ Risperidone
Q23 Which one of the following antipsychotic drugs has the lowest 
risk of sexual dysfunction?
○ Risperidone
○ Flupentixol
○ Aripiprazole
○ Haloperidol
Q24 Hyperglycaemia, weight gain and sometimes Diabetes is more 
likely to occur with which one of the following second generation 
antipsychotics?
○ Clozapine
○ Aripiprazole
○ Lurasidone
○ Asenapine
